Trials / Completed
CompletedNCT01436838
China Betaferon Adherence, Coping and Nurse Support Study
Prospective Study of Betaferon in Adherence, Coping and Nurse Support in Patients of Chinese Origin With Multiple Sclerosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Non-adherence reduces treatment benefit and can bias the assessment of treatment efficacy thereby involving safety risks for the patient and influencing health cost-effectiveness. This observational study will concentrate upon the role of MS nurses in influencing adherence. This study will examine the influence of initial and subsequent periodic nurse interviews which aim to improve adherence to Betaferon® treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Interferon beta-1b (Betaseron, BAY86-5046) | All patients will be prescribed with Betaseron and be instructed on treatment by their phisicians |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2015-09-01
- Completion
- 2015-12-01
- First posted
- 2011-09-20
- Last updated
- 2016-09-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01436838. Inclusion in this directory is not an endorsement.